- Home
- RKDA vs NXTS Comparison
RKDA vs NXTS Comparison
Compare RKDA & NXTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RKDA | NXTS |
|---|---|---|
| Founded | 2002 | 2009 |
| Country | United States | Israel |
| Employees | N/A | 9 |
| Industry | Agricultural Chemicals | Agricultural Chemicals |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9M | 3.6M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | RKDA | NXTS |
|---|---|---|
| Price | $0.93 | $5.84 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 39.0K |
| Earning Date | 05-07-2026 | 05-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 66.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,858,000.00 | N/A |
| Revenue This Year | $61.67 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.80 | $0.55 |
| 52 Week High | $6.71 | $6.25 |
Technical Indicators
Market Signals| Indicator | RKDA | NXTS |
|---|---|---|
| Relative Strength Index (RSI) | 37.57 | 65.71 |
| Support Level | $0.85 | $3.97 |
| Resistance Level | $1.51 | $6.23 |
| Average True Range (ATR) | 0.16 | 0.71 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 16.82 | 65.20 |
Price Performance
Historical ComparisonAbout RKDA Arcadia Biosciences Inc.
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
About NXTS Nexentis Technologies Inc. Common Stock
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.